Wölffer, M.; Battke, F.; Schulze, M.; Feldhahn, M.; Flatz, L.; Martus, P.; Forschner, A.
Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma. Cancers 2022, 14, 302.
https://doi.org/10.3390/cancers14020302
AMA Style
Wölffer M, Battke F, Schulze M, Feldhahn M, Flatz L, Martus P, Forschner A.
Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma. Cancers. 2022; 14(2):302.
https://doi.org/10.3390/cancers14020302
Chicago/Turabian Style
Wölffer, Marcus, Florian Battke, Martin Schulze, Magdalena Feldhahn, Lukas Flatz, Peter Martus, and Andrea Forschner.
2022. "Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma" Cancers 14, no. 2: 302.
https://doi.org/10.3390/cancers14020302
APA Style
Wölffer, M., Battke, F., Schulze, M., Feldhahn, M., Flatz, L., Martus, P., & Forschner, A.
(2022). Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma. Cancers, 14(2), 302.
https://doi.org/10.3390/cancers14020302